Antimicrobial resistance was back on the agenda when the 148th WHO Executive Board which took place from January 18-26. A number of ReAct's nodes developed position documents for Member State delegates and the WHO to consider in response to the stock taking report produced by the WHO secretariat.
The input documents highlighted a number of key points including:
- the urgent need for establishing global governance structures and the development of key performance indicators,
- increased efforts for mobilize financial support for the implementation of National action plans,
- initiatives to mobilize and engage youth on the issue of antimicrobial resistance,
- renewed efforts to resolve the crisis in Research & Development of new antibiotics,
as well as a more active role of the WHO in generating actionable data on the global and national resistance situation through point prevalence studies.
Read more in the documents below
ReAct North America
ReAct Asia Pacific
More from "2021"
- 4 considerations for addressing antimicrobial resistance through pandemic preparedness
- Preventing the next pandemic: Addressing antibiotic resistance
- 4 key takeaways from the virtual ReAct Africa Conference 2020
- The threat of the unknown: is lack of global burden data slowing down work on antibiotic resistance?
- ReAct input to the WHO Executive Board Session on Antimicrobial Resistance
- Dr Gautham: informal health providers key to reducing antibiotic use in rural India